Adherence to Kidney Disease: Improving Global Outcomes Mineral and Bone Guidelines for Monitoring Biochemical Parameters
Conclusions: In fee-for-service Medicare beneficiaries, laboratory testing for CKD-MBD biochemical markers appears to be suboptimal in relation to KDIGO guidelines. Competing priories, such as management of comorbid disease and preparation for renal replacement therapy, may distract from CKD-MBD monitoring.Am J Nephrol 2019;49:225 –232
Source: American Journal of Nephrology - Category: Neurology Source Type: research
More News: Calcium | Cardiology | Cardiovascular | Chronic Kidney Disease | Heart | Hormones | Laboratory Medicine | Medicare | Neurology | Orthopaedics | Phosphorus | Urology & Nephrology | Women